09:00 EDT VistaGen Therapeutics trading resumes
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTGN:
- Vistagen (NASDAQ:VTGN) Skyrockets over 600% on Positive Phase 3 Data for Social Anxiety Disorder
- Vistagen announces new itruvone data
- Vistagen receives notice of allowance for AV-101 Canadian patent
- Vistagen reports FY23 net loss $59.2M vs. $48.7M last year
- VTGN Upcoming Earnings Report: What to Expect?